Auro-Valacyclovir 500 mg – DIN 02405040
Auro-Valacyclovir is Valacyclovir Hydrochloride 500 mg (tablet), sold in Canada. It is used for shingles, genital herpes and cold sores. It is supplied by Auro Pharma Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Valacyclovir Hydrochloride 500 mg
- Brand
- Auro-Valacyclovir
- Strength
- 500 mg
- Used for
- Shingles, genital herpes and cold sores
- Form
- Tablet
- Manufacturer
- Auro Pharma Inc
- Drug class
- Antiviral
- Sold in
- Canada
- DIN
- 02405040
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Valacyclovir used for?
Valacyclovir is used for shingles, genital herpes, cold sores and chickenpox.
- Medicine type
- Antiviral
Official uses from the US prescribing label
Adult Patients
Cold Sores (Herpes Labialis) Valacyclovir tablets are indicated for treatment of cold sores (herpes labialis). The efficacy of valacyclovir tablets initiated after the development of clinical signs of a cold sore (e.g., papule, vesicle, or ulcer) has not been established. Genital Herpes Initial Episode: Valacyclovir tablets are indicated for treatment of the initial episode of genital herpes in immunocompetent adults. The efficacy of treatment with valacyclovir tablets when initiated more than 72 hours after the onset of signs and symptoms has not been established. Recurrent Episodes: Valacyclovir tablets are indicated for treatment of recurrent episodes of genital herpes in immunocompetent adults. The efficacy of treatment with valacyclovir tablets when initiated more than 24 hours after the onset of signs and symptoms has not been established. Suppressive Therapy: Valacyclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes in immunocompetent and in HIV-1-infected adults. The efficacy and safety of valacyclovir tablets for the suppression of genital herpes beyond 1 year in immunocompetent patients and beyond 6 months in HIV-1-infected patients have not been established. Reduction of Transmission: Valacyclovir tablets are indicated for the reduction of transmission of genital herpes in immunocompetent adults. The efficacy of valacyclovir tablets for the reduction of transmission of genital herpes beyond 8 months in discordant couples has not been established. The efficacy of valacyclovir tablets for the reduction of transmission of genital herpes in individuals with multiple partners and non-heterosexual couples has not been established. Safer sex practices should be used with suppressive therapy (see current Centers for Disease Control and Prevention [CDC] Sexually Transmitted Diseases Treatment Guidelines). Herpes Zoster Valacyclovir tablets are indicated for the treatment of herpes zoster (shingles) in immunocompetent adults. The efficacy of valacyclovir tablets when initiated more than 72 hours after the onset of rash and the efficacy and safety of valacyclovir tablets for treatment of disseminated herpes zoster have not been established.
Pediatric Patients
Cold Sores (Herpes Labialis)
Valacyclovir tablets are indicated for the treatment of cold sores (herpes labialis) in pediatric patients aged greater than or equal to 12 years. The efficacy of valacyclovir tablets initiated after the development of clinical signs of a cold sore (e.g., papule, vesicle, or ulcer) has not been established.
Chickenpox
Valacyclovir tablets are indicated for the treatment of chickenpox in immunocompetent pediatric patients aged 2 to less than 18 years. Based on efficacy data from clinical trials with oral acyclovir, treatment with valacyclovir tablets should be initiated within 24 hours after the onset of rash.
Limitations of Use
The efficacy and safety of valacyclovir tablets have not been established in:
- Immunocompromised patients other than for the suppression of genital herpes in HIV-1-infected patients with a CD4+ cell count greater than or equal to 100 cells/mm3.
- Patients aged less than 12 years with cold sores (herpes labialis).
- Patients aged less than 2 years or greater than or equal to 18 years with chickenpox.
- Patients aged less than 18 years with genital herpes.
- Patients aged less than 18 years with herpes zoster.
- Neonates and infants as suppressive therapy following neonatal herpes simplex virus (HSV) infection.
From the FDA-approved label on DailyMed (published Aug 25, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02405040.
- It names Auro-Valacyclovir, Valacyclovir Hydrochloride 500 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Auro-Valacyclovir by Auro Pharma Inc.
In Canada: prescription only.
Ingredients
Active: Valacyclovir (Valacyclovir Hydrochloride)
Other Valacyclovir pills
-
F 8 3
Valacyclovir Hydrochloride 1 g
Blue, capsule, 23 mm
Used for shingles and genital herpes
-
F 82
Valacyclovir Hydrochloride 500 mg
Blue, capsule, 18 mm
Used for shingles and genital herpes
- WPI 3249 Valacyclovir Hydrochloride 1 g Blue, capsule, 21 mm Used for shingles and genital herpes
- VALTREX 1 gram Valacyclovir Hydrochloride 1 g Blue, capsule, 23 mm Used for shingles and genital herpes
- W153 Valacyclovir Hydrochloride 1 g Blue, capsule, 23 mm Used for shingles and genital herpes
- 93 7259 Valacyclovir Hydrochloride 1 g Blue, capsule, 23 mm Used for shingles and genital herpes
- C3251000 Valacyclovir Hydrochloride 1 g Blue, capsule, 23 mm Used for shingles and genital herpes
- SZ 394 Valacyclovir 1 g Blue, capsule, 23 mm Used for shingles and genital herpes